Smoke-free legislation and childhood hospitalisations for respiratory tract infections

Eur Respir J. 2015 Sep;46(3):697-706. doi: 10.1183/09031936.00014615. Epub 2015 May 28.

Abstract

Second-hand smoke exposure is a major risk factor for respiratory tract infections (RTIs). Although evidence suggests important early-life health benefits of smoke-free public environments, the impact on childhood RTIs is unclear. We investigated the association between England's smoke-free legislation and childhood RTI hospitalisations.We used the Hospital Episode Statistics database to obtain nationwide data on hospital admissions for acute RTIs among children (<15 years of age) from 2001 to 2012. Hospitalisation counts were disaggregated by month, age group, sex and small-area level, and linked to urbanisation, region, deprivation index and corresponding population estimates. Negative binomial regression analyses were adjusted for confounders, seasonal variation, temporal autocorrelation, population-size changes and underlying incidence trends. Models allowed for sudden and gradual changes following the smoke-free legislation. We performed sensitivity and subgroup analyses, and estimated number of events prevented.We analysed 1 651 675 hospital admissions. Introduction of smoke-free legislation was followed by an immediate reduction in RTI admissions (-3.5%, 95% CI -4.7- -2.3%), this mainly being attributable to a decrease in lower RTI admissions (-13.8%, 95% CI -15.6- -12.0%). The reductions in admissions for upper RTI were more incremental.The introduction of national smoke-free legislation in England was associated with ∼11 000 fewer hospital admissions per year for RTIs in children.

Trial registration: ClinicalTrials.gov NCT01920165.

MeSH terms

  • Adolescent
  • Age Distribution
  • Child
  • Child, Preschool
  • Databases, Factual
  • Female
  • Hospitalization / statistics & numerical data*
  • Humans
  • Incidence
  • Male
  • Multivariate Analysis
  • Patient Admission / statistics & numerical data*
  • Regression Analysis
  • Respiratory Tract Infections / diagnosis*
  • Respiratory Tract Infections / epidemiology*
  • Respiratory Tract Infections / therapy
  • Retrospective Studies
  • Risk Assessment
  • Sex Distribution
  • Tobacco Smoke Pollution / adverse effects
  • Tobacco Smoke Pollution / legislation & jurisprudence*
  • United Kingdom

Substances

  • Tobacco Smoke Pollution

Associated data

  • ClinicalTrials.gov/NCT01920165